Peptide Research
Educational research overviews for the peptides studied in preclinical and laboratory contexts. Each article walks through the simplified summary, mechanisms, research applications, and current evidence — for research use only.
AOD-9604 Peptide Research Overview
Simplified Summary AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically engineered for use in laboratory research focused on metabolism and fat regulation. Unlike full-length growth hormone, AOD-9604 has been studied in preclinical settings for its potential to influence lipid-related processes without engaging broader growth-promoting pathways. Its structure—a short amino acid sequence—has made it a subject of interest in controlled experimental models exploring metabolic signaling.
Read research overview →
Argireline (Acetyl Hexapeptide-8) Research Overview
Simplified Summary Argireline (Acetyl Hexapeptide-8) is a synthetic peptide that has been widely examined in preclinical research for its potential role in modulating neuromuscular signaling and peptide-mediated communication. Structurally, it is a short chain of amino acids designed to mimic specific segments of naturally occurring proteins involved in neurotransmitter release. Unlike endogenous peptides, Argireline is engineered for stability and consistency in controlled experimental settings, making it a common subject in laboratory-based investigations.
Read research overview →
BPC-157, Thymosin Beta-4, and GHK-Cu Peptide Research Overview
Simplified Summary BPC-157, Thymosin Beta-4 (Tβ4), and GHK-Cu are endogenously derived peptides that have been independently investigated in preclinical research for their roles in tissue repair, angiogenesis, extracellular matrix remodeling, and inflammation-associated cellular signaling. These peptides differ substantially in molecular structure and biological origin: BPC-157 is a stable gastric-derived pentadecapeptide, Thymosin Beta-4 is a ubiquitously expressed actin-binding peptide, and GHK-Cu is a copper-chelating tripeptide involved in redox- and matrix-related pathways. Despite these differences,…
Read research overview →
Bronchogen Peptide Research
Simplified Summary Bronchogen is a short, synthetic tetrapeptide composed of the amino acid sequence Ala-Glu-Asp-Leu (AEDL) that has been investigated as a tissue-specific bioregulatory peptide associated with bronchial and lung tissues. It belongs to a broader class of organ-derived peptides originally identified through fractionation of animal tissue extracts and subsequently synthesized for experimental research. This class of compounds was developed to address limitations observed in age- and stress-related decline in endogenous regulatory signaling within specific tissues.
Read research overview →
Cardiogen Peptide Research
Simplified Summary Cardiogen is a short, synthetic tetrapeptide developed for experimental investigation into cardiac tissue regulation. It is derived from naturally occurring peptide fragments identified in myocardial tissue and is structurally composed of the amino acid sequence Ala-Glu-Asp-Arg (AEDR). Cardiogen belongs to a class of compounds commonly described as tissue-specific peptide bioregulators, which have been studied for their capacity to influence gene expression and cellular maintenance processes in organ-specific contexts.
Read research overview →
Cartalax Peptide Research
Simplified Summary Cartalax is a short, cartilage-specific peptide bioregulator investigated in experimental research for its role in regulating gene expression and cellular homeostasis in cartilage tissue. Structurally defined as the tripeptide Ala-Glu-Asp (AED), Cartalax was originally identified through peptide fractionation of animal cartilage extracts and is classified within a family of organ-specific cytomedins. These peptides are characterized by their small size and their reported capacity to influence transcriptional activity in cells derived from their tissue of origin.
Read research overview →
Cerebrolysin-Derived Peptides Research Overview
Simplified Summary Cerebrolysin-derived peptides represent a complex mixture of low-molecular weight peptide fragments originally obtained through enzymatic breakdown of porcine brain proteins. In research settings, these peptides are studied for their potential to mimic or influence neurotrophic activity—processes that support neuronal growth, signaling, and structural maintenance. Rather than a single defined peptide, this category encompasses multiple bioactive fragments, each potentially interacting with different pathways within the central nervous system under controlled experimental conditions.
Read research overview →
CJC-1295 Peptide Research Overview
Simplified Summary CJC-1295 is a synthetic peptide analog that has been investigated in preclinical research for its potential role in modulating growth hormone (GH) signaling and endocrine system activity. Structurally designed to mimic growth hormone-releasing hormone (GHRH), CJC-1295 has been studied for its ability to interact with GHRH receptors and influence pulsatile GH release under controlled laboratory conditions. Unlike naturally occurring peptides, it is engineered with modifications intended to extend its stability and duration of action in experimental models.
Read research overview →
Copper Peptides (GHK-Cu Expanded Study) Research Overview
Simplified Summary Copper Peptides, particularly GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper), are naturally occurring complexes that have been widely studied in preclinical research for their potential role in cellular signaling and tissue-related processes. First identified in human plasma, GHK has a strong affinity for copper ions, forming GHK-Cu—a biologically active complex that has been explored for its involvement in regenerative and protective mechanisms at the cellular level. Unlike fully synthetic peptides, GHK is considered endogenous, though its broader biological functions continue to be…
Read research overview →
Dihexa Peptide Research
Simplified Summary Dihexa is a small, laboratory-designed peptide developed for scientific investigation into mechanisms underlying synaptic connectivity, learning, and memory formation. It is a fully synthetic compound that does not occur naturally in the human body. Dihexa was derived from a short active fragment of angiotensin IV, a peptide associated with cognitive processes within the brain's local renin-angiotensin system. Structural modifications were introduced to improve metabolic stability, prolong biological activity, and enhance penetration of the blood-brain barrier—limitations that restricted…
Read research overview →
DSIP Peptide Research Overview
Simplified Summary Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring peptide that has been investigated in preclinical research for its potential involvement in sleep-related regulation and neuroendocrine signaling. Initially identified in association with sleep physiology, DSIP consists of a short chain of amino acids and has been studied primarily for its interactions within central nervous system pathways under controlled experimental conditions. Unlike many fully synthetic peptides, DSIP is considered endogenous in origin, though much of its function remains under active scientific exploration.
Read research overview →
Epitalon (Epithalon) Peptide Research Overview
Simplified Summary Epitalon (Epithalon) is a synthetic peptide that has been widely explored in preclinical research for its potential role in cellular aging and biological regulation. Derived from a naturally occurring peptide known as epithalamin—associated with the pineal gland—Epitalon consists of a short chain of amino acids and has been studied for its possible influence on molecular processes linked to longevity and cellular stability. Unlike many peptides designed purely in laboratories, Epitalon is modeled after endogenous compounds, though its full biological significance remains under active…
Read research overview →
Follistatin 344 Peptide Research Overview
Simplified Summary Follistatin 344 is a biologically derived peptide variant that has been widely examined in preclinical research for its role in regulating protein interactions involved in tissue development and cellular growth. It is a naturally occurring isoform of follistatin, a glycoprotein known for its binding affinity to members of the transforming growth factor-beta (TGF-β) superfamily, particularly myostatin and activins. Unlike fully synthetic compounds, Follistatin 344 originates from endogenous biological processes, though its broader functional implications continue to be explored in…
Read research overview →
FOXO4-DRI Peptide Research Overview
Simplified Summary FOXO4-DRI is a synthetically engineered peptide developed for use in preclinical research focused on cellular aging and senescence. Unlike naturally occurring peptides, FOXO4-DRI is designed to interfere with specific protein-protein interactions—particularly those involving the transcription factor FOXO4 and the tumor suppressor protein p53. These interactions are believed to play a role in the survival of senescent cells, which accumulate over time and are commonly studied in relation to aging processes in controlled laboratory environments.
Read research overview →
GDF-11 Peptide Research Overview
Simplified Summary Growth Differentiation Factor 11 (GDF-11) is a protein belonging to the transforming growth factor-beta (TGF-β) superfamily that has been investigated in preclinical research for its potential role in cellular signaling and tissue-related processes. Naturally expressed in various organisms, GDF-11 is considered endogenous and is structurally characterized as a regulatory growth factor involved in developmental and biological patterning. While early research focused on its role during embryonic development, more recent studies have explored its activity in adult biological systems under…
Read research overview →
GHRP-2 / GHRP-6 Peptide Research Overview
Simplified Summary Growth Hormone-Releasing Peptides, specifically GHRP-2 and GHRP-6, are synthetic peptide compounds that have been widely investigated in preclinical research for their potential role in stimulating growth hormone release and modulating endocrine signaling pathways. These peptides are composed of short amino acid chains designed to interact with specific receptors involved in hormonal regulation, particularly within the hypothalamic-pituitary axis.
Read research overview →
Humanin Peptide Research
Simplified Summary Humanin is a mitochondria-encoded peptide that has been investigated extensively in preclinical research as a regulator of cellular stress responses. First identified in experimental screens for factors that attenuate neuronal cell death, Humanin is now recognized as a member of the broader class of mitochondrial-derived peptides involved in intracellular and intercellular signaling. The peptide is composed of 24 amino acids and is encoded within the mitochondrial 16S ribosomal RNA gene, distinguishing it from nuclear-encoded signaling peptides.
Read research overview →
Ipamorelin Peptide Research Overview
Simplified Summary Ipamorelin is a synthetic peptide that has been widely investigated in preclinical research for its selective interaction with growth hormone-related signaling pathways. Classified as a growth hormone secretagogue, Ipamorelin is designed to mimic the activity of endogenous ligands that bind to specific receptors involved in endocrine regulation. Structurally, it is a short chain of amino acids engineered to interact with the growth hormone secretagogue receptor (GHS-R), making it a point of interest in controlled experimental models focused on hormonal modulation.
Read research overview →
KPV Peptide Research Overview
Simplified Summary KPV (Lysine-Proline-Valine) is a short-chain peptide fragment derived from the larger melanocortin peptide Alpha-Melanocyte-Stimulating Hormone (α-MSH). In preclinical research, KPV has been investigated for its potential involvement in inflammatory signaling and immune-related processes. Due to its compact structure—composed of just three amino acids—it has attracted attention in experimental models exploring peptide-mediated regulatory mechanisms, particularly those associated with localized tissue responses.
Read research overview →
LL-37 Antimicrobial Peptide Research Overview
Simplified Summary LL-37 is a naturally occurring antimicrobial peptide that has been extensively examined in preclinical research for its potential role in host defense and immune system regulation. Derived from the human cathelicidin precursor protein (hCAP18), LL-37 consists of a short chain of amino acids and is widely studied for its activity within innate immune pathways under controlled experimental conditions. As an endogenous peptide, it is recognized for its broad-spectrum antimicrobial properties, though many aspects of its biological function remain under active scientific investigation.
Read research overview →
Matrixyl (Palmitoyl Pentapeptide) Research Overview
Simplified Summary Matrixyl, commonly known as Palmitoyl Pentapeptide, is a synthetically derived peptide that has been widely investigated in preclinical research for its potential role in extracellular matrix signaling and structural protein dynamics. Composed of a short chain of amino acids linked to a fatty acid (palmitic acid), Matrixyl is designed to enhance stability and facilitate interaction within cellular environments. Unlike endogenous peptides, it is engineered to mimic naturally occurring signaling fragments involved in tissue remodeling processes, making it a subject of interest in…
Read research overview →
MOTS-c Peptide Research Overview
Simplified Summary Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) is a mitochondrial-derived peptide that has been investigated in preclinical research for its potential role in cellular metabolism and energy regulation. Unlike many peptides encoded in the nuclear genome, MOTS-c originates from mitochondrial DNA, making it a unique subject of study in the context of intracellular signaling and metabolic adaptation. It consists of a short chain of amino acids and has been primarily examined in laboratory and animal-based models under controlled experimental conditions.
Read research overview →
Non-Canonical Amino Acid Peptides Research Overview
Simplified Summary Non-canonical amino acid peptides represent a class of engineered or naturally inspired molecules that incorporate amino acids beyond the standard twenty found in conventional protein structures. In research settings, these modified peptides are explored for how structural variations—such as altered side chains, backbone modifications, or synthetic residues—may influence molecular stability, binding behavior, and resistance to enzymatic degradation. Unlike strictly endogenous peptides, many of these constructs are deliberately designed to expand the functional possibilities of…
Read research overview →
Noopept (Peptide-like Nootropic) Research Overview
Simplified Summary Noopept is a synthetic compound often described as a peptide-like nootropic, meaning its structure and activity share certain characteristics with small regulatory peptides studied in neuroscience. Although not classified as a true peptide, it has been widely examined in preclinical research for its potential interactions with cognitive and neuroprotective pathways. Much of the scientific interest in Noopept stems from its compact molecular structure and its proposed ability to influence signaling processes within the central nervous system under controlled laboratory conditions.
Read research overview →
PEG-MGF (Mechano Growth Factor) Research Overview
Simplified Summary PEG-MGF (Pegylated Mechano Growth Factor) is a modified variant of mechano growth factor, a peptide derived from the Insulin-like Growth Factor 1 system that has been investigated in preclinical research for its potential role in muscle repair and cellular adaptation. MGF itself is produced locally in response to mechanical stress or tissue strain, particularly in muscle fibers. The pegylated form (PEG-MGF) is engineered to extend stability and persistence in experimental settings, allowing researchers to more effectively observe its biological activity.
Read research overview →
Peptide Drug Conjugates (PDCs) Research Overview
Simplified Summary Peptide Drug Conjugates (PDCs) are engineered constructs that combine biologically active peptides with therapeutic payloads, designed to investigate targeted delivery and controlled activity in preclinical research settings. Unlike standalone peptides, PDCs integrate a peptide component—often selected for its binding affinity or receptor specificity—with a conjugated molecule such as a small drug compound, imaging agent, or other functional cargo. This modular structure has positioned PDCs as a growing area of interest in experimental pharmacology and molecular targeting strategies.
Read research overview →
Peptide Vaccines (E75, GP2, AE37) Research Overview
Simplified Summary Peptide vaccines such as E75, GP2, and AE37 have been widely examined in preclinical and early-stage research for their potential role in stimulating targeted immune responses, particularly in oncology-focused experimental models. These peptides are derived from fragments of tumor-associated antigens—most notably the HER2/neu protein—and are designed to help the immune system recognize and respond to specific cellular markers under controlled laboratory conditions. Unlike endogenous peptides, these compounds are synthetically engineered to enhance immunogenicity and direct immune activity…
Read research overview →
Pinealon Peptide Research
Simplified Summary Pinealon is an ultrashort regulatory peptide composed of three amino acids—glutamic acid, aspartic acid, and arginine (Glu-Asp-Arg)—that has been investigated in preclinical research examining cellular stress regulation in neural systems. It has been studied primarily in in vitro and animal models relevant to oxidative stress, hypoxia, and age-associated neuronal changes, where cellular vulnerability and stress-response signaling are key areas of investigation.
Read research overview →
Selank Peptide Research Overview
Simplified Summary Selank is a synthetic peptide that has been widely explored in preclinical research for its role in modulating neurochemical signaling and stress-related responses. Originally developed as an analog of the naturally occurring immunomodulatory peptide tuftsin, Selank consists of seven amino acids and has been studied for its stability and activity within experimental systems. Unlike mitochondrial-derived peptides, Selank is engineered and examined primarily for its influence on central nervous system signaling pathways.
Read research overview →
Self-Assembling Peptides Research Overview
Simplified Summary Self-assembling peptides are short chains of amino acids designed or observed to spontaneously organize into structured arrangements under specific environmental conditions. In preclinical research, these peptides have drawn attention for their ability to form well-defined nanostructures—such as fibers, sheets, or hydrogels—through non-covalent interactions like hydrogen bonding, electrostatic forces, and hydrophobic effects. This self-organization process has positioned them as a valuable model for studying biomolecular assembly and material formation at the nanoscale.
Read research overview →
Semaglutide (GLP-1) Peptide Research Overview
Simplified Summary Semaglutide (GLP-1) is a synthetic peptide analog modeled after glucagon-like peptide-1 (GLP-1), a naturally occurring hormone involved in metabolic signaling. In preclinical research, it has been examined for its interaction with GLP-1 receptors, which are widely distributed across various tissues, including the pancreas, gastrointestinal system, and central nervous system. Structurally modified to enhance stability and prolong activity, semaglutide allows researchers to explore sustained receptor engagement under controlled experimental conditions. Despite its design being inspired by an…
Read research overview →
Semax Peptide Research Overview
Simplified Summary Semax is a synthetic peptide that has been extensively examined in preclinical research for its potential role in neuroregulation and cognitive-associated signaling pathways. Derived as an analog of a fragment of adrenocorticotropic hormone (ACTH), Semax is composed of a short chain of amino acids engineered to enhance stability and functional activity within experimental models. Unlike peptides originating from mitochondrial processes, Semax is synthetically designed and primarily investigated for its interaction with central nervous system mechanisms.
Read research overview →
Snap-8 Peptide Research Overview
Simplified Summary Snap-8, also known as Acetyl Octapeptide-3, is a synthetic peptide that has been explored in preclinical research for its potential role in modulating neurotransmitter release and neuromuscular signaling. Structurally derived as an analog of SNAP-25—a protein involved in synaptic vesicle fusion—Snap-8 consists of a short amino acid sequence engineered to mimic specific regulatory functions within cellular communication pathways. Unlike endogenous peptides, Snap-8 is fully synthetic and designed for targeted investigation under controlled laboratory conditions.
Read research overview →
TB-500 Peptide Research Overview
Simplified Summary Thymosin Beta-4 Fragment (TB-500) is a synthetic peptide derived from a naturally occurring protein known as Thymosin Beta-4, which has been widely studied in preclinical research for its potential role in cellular repair and regeneration processes. As a fragment-based analog, TB-500 is designed to mirror specific functional regions of the parent peptide, particularly those associated with cell migration, structural organization, and tissue remodeling. Research into TB-500 is conducted primarily in controlled laboratory and animal-based models, with a focus on understanding its biological…
Read research overview →
Tesamorelin Peptide Research Overview
Simplified Summary Tesamorelin is a synthetic peptide analog modeled after growth hormone-releasing hormone (GHRH) and has been widely examined in preclinical research for its role in regulating growth hormone dynamics and associated metabolic processes. Structurally, it consists of a stabilized chain of amino acids designed to mimic endogenous signaling while improving resistance to enzymatic degradation in experimental environments. Unlike naturally occurring peptides, Tesamorelin is fully synthetic, allowing for more consistent investigation under controlled laboratory conditions.
Read research overview →
Testagen Peptide Research
Simplified Summary Testagen is a short synthetic peptide belonging to the class of tissue-specific peptide bioregulators originally described in Russian and Eastern European gerontology research. It is composed of a defined amino acid sequence designed to mirror naturally occurring regulatory peptides isolated from mammalian endocrine tissues, particularly the testes. Testagen does not function as a hormone and is not known to directly activate classical endocrine receptors. Instead, it has been investigated as a gene-regulatory signaling peptide capable of influencing transcriptional activity within…
Read research overview →
Thymosin Alpha-1 Peptide Research Overview
Simplified Summary Thymosin Alpha-1 (Tα1) is a naturally derived peptide that has been widely examined in preclinical research for its potential role in immune system regulation and cellular signaling. Originally isolated from the thymus, this peptide is composed of a short chain of amino acids and is considered endogenous in origin. Scientific interest in Thymosin Alpha-1 has largely centered on how it may interact with immune pathways under controlled laboratory conditions, particularly in relation to host defense mechanisms and cellular communication.
Read research overview →
Thymulin Peptide Research Overview
Simplified Summary Thymulin is a naturally occurring peptide produced by the thymus gland and has been widely studied in preclinical research for its role in immune system signaling and regulation. Structurally, it is a nonapeptide that becomes biologically active when associated with zinc, forming a complex that has been observed to participate in immune cell differentiation and function. Because of its endogenous origin, Thymulin is often explored as part of broader investigations into thymic activity and immune system development under controlled experimental conditions.
Read research overview →
Tirzepatide Peptide Research Overview
Simplified Summary Tirzepatide is a synthetic peptide that has been widely investigated in preclinical research for its interaction with metabolic signaling pathways. Structurally designed to act on both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, it represents a dual incretin receptor agonist studied under controlled experimental conditions. Unlike endogenous peptides, tirzepatide is engineered to mimic and enhance naturally occurring hormonal signals involved in energy balance and glucose regulation, though its full range of mechanisms continues to be…
Read research overview →
Vilon Peptide Research
Simplified Summary Vilon is a short regulatory peptide that has been studied in preclinical research programs examining thymus-associated peptides and their role in immune-related cellular regulation. It has been evaluated primarily in experimental models of immune aging and immune system dysregulation, where alterations in gene expression and signaling balance are commonly observed. Vilon belongs to a group of low-molecular-weight peptides investigated for their ability to influence intracellular regulatory processes rather than acting through membrane-bound receptors or classical hormonal pathways.
Read research overview →
Retatrutide (GLP-1/GIP/Glucagon Triple Agonist) Research Overview
Simplified Summary Retatrutide is a synthetic triple receptor agonist studied in preclinical models for its simultaneous engagement of GLP-1, GIP, and glucagon receptors. Its multi-receptor profile has made it a subject of considerable metabolic research interest, particularly for understanding coordinated energy expenditure, adipose tissue dynamics, and hepatic lipid regulation.
Read research overview →
Mazdutide (GLP-1/Glucagon Dual Agonist) Research Overview
Simplified Summary Mazdutide (IBI362) is a GLP-1 and glucagon dual receptor agonist developed by Innovent Biologics, studied in preclinical models for its effects on metabolic signalling, lipid metabolism, and hepatic fat accumulation. Its dual receptor profile has been examined as a tool for understanding coordinated incretin and glucagon pathway interactions.
Read research overview →
Survodutide (BI 456906) Research Overview
Simplified Summary Survodutide (BI 456906) is a GLP-1 and glucagon dual receptor agonist developed by Boehringer Ingelheim, studied in preclinical models for metabolic regulation and hepatic biology. It has received particular attention in preclinical NASH model research for its effects on hepatic steatosis, inflammation, and fibrosis markers.
Read research overview →
Cagrilintide (Long-Acting Amylin Analogue) Research Overview
Simplified Summary Cagrilintide is a long-acting synthetic analogue of the pancreatic hormone amylin, engineered for extended duration of action. Preclinical research has studied its effects on satiety signalling, gastric motility, and metabolic regulation. It has also been investigated in preclinical combination studies with semaglutide (CagriSema) to examine additive or synergistic metabolic outcomes.
Read research overview →
Adipotide (FTPP) Peptide Research Overview
Simplified Summary Adipotide (FTPP) is a chimeric peptide designed to selectively target the vasculature supplying white adipose tissue through binding to PROHIBITIN expressed on adipose endothelium. Preclinical research has studied its pro-apoptotic effects on adipose vasculature in animal models, making it a research tool for studying adipose tissue vascular biology.
Read research overview →
5-Amino-1MQ (NNMT Inhibitor) Research Overview
Simplified Summary 5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates cellular NAD+ metabolism. Preclinical research has studied its effects on NAD+ pathway modulation, adipocyte differentiation, and metabolic regulation in cell-based and animal model systems.
Read research overview →
SLU-PP-332 (ERRα/ERRγ Agonist) Research Overview
Simplified Summary SLU-PP-332 is a synthetic small molecule agonist of the estrogen-related receptors ERRα and ERRγ, orphan nuclear receptors that regulate mitochondrial biogenesis and oxidative metabolism. Preclinical research has studied its exercise-mimetic effects, including mitochondrial biogenesis, skeletal muscle oxidative capacity, and endurance-related metabolic pathway activation in animal models.
Read research overview →
SS-31 (Elamipretide) Mitochondria-Targeted Peptide Research Overview
Simplified Summary SS-31 (also known as Elamipretide, MTP-131, or Bendavia) is a synthetic tetrapeptide that localises to the inner mitochondrial membrane by binding cardiolipin, a phospholipid integral to mitochondrial function. Preclinical research has studied SS-31 extensively as a tool for investigating mitochondrial biology, oxidative stress, and cellular energy metabolism in a wide range of disease model systems.
Read research overview →
BAM-15 (Mitochondrial Uncoupler) Research Overview
Simplified Summary BAM-15 is a synthetic mitochondrial protonophore and uncoupling agent studied in preclinical models for its ability to dissipate the mitochondrial proton gradient, thereby increasing metabolic rate and energy expenditure without stimulating the central nervous system. Preclinical research has examined its effects on adipose tissue, hepatic lipid metabolism, and whole-body energy balance in animal model systems.
Read research overview →
ARA-290 (Innate Repair Receptor Agonist) Research Overview
Simplified Summary ARA-290 is a synthetic peptide derived from the helix B region of erythropoietin (EPO), designed to selectively activate the innate repair receptor (IRR) while avoiding the haematopoietic receptor that mediates EPO's red blood cell effects. Preclinical research has studied ARA-290 for its neuroprotective, anti-inflammatory, and metabolic properties in animal models of neuropathy, diabetes, and inflammatory disease.
Read research overview →
PE-22-28 (TRPC6 Agonist) Peptide Research Overview
Simplified Summary PE-22-28 is a synthetic peptide fragment derived from spadin, itself a cleavage product of the NTSR3/sortilin protein, studied in preclinical models for its effects on neuroplasticity and neural circuit biology through activation of TRPC6 calcium channels. Preclinical research has examined its antidepressant-like effects, synaptic plasticity modulation, and neurogenesis-related outcomes in animal models.
Read research overview →
Sermorelin (GHRH Analogue) Peptide Research Overview
Simplified Summary Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the endogenous 44-amino acid GHRH peptide, representing the biologically active fragment required for growth hormone receptor binding. Preclinical research has studied sermorelin as a tool for investigating the hypothalamic-pituitary GH axis and the consequences of stimulated endogenous growth hormone release in animal model systems.
Read research overview →
Human Growth Hormone (HGH / Somatropin) Research Overview
Simplified Summary Recombinant human growth hormone (rhGH, somatropin) is a 191-amino acid protein used extensively in preclinical and laboratory research settings to study the growth hormone-IGF-1 axis, anabolic processes, metabolic regulation, and body composition biology. Preclinical research has characterised its receptor binding properties, tissue-specific effects, and role in regulating protein synthesis, lipolysis, and carbohydrate metabolism across diverse animal model systems.
Read research overview →
IGF-1 LR3 (Long Arginine 3 IGF-1) Research Overview
Simplified Summary IGF-1 LR3 (Long Arginine 3 Insulin-like Growth Factor-1) is a synthetic analogue of IGF-1 engineered with an N-terminal 13-amino acid extension and an arginine substitution at position 3, producing a compound with significantly reduced binding affinity for IGF-binding proteins (IGFBPs) and consequently extended biological activity compared to native IGF-1. Preclinical research has used IGF-1 LR3 as a tool for investigating IGF-1 receptor biology, anabolic signalling, and cell proliferation in laboratory model systems.
Read research overview →
Hexarelin (GHRP-6 Analogue) Research Overview
Simplified Summary Hexarelin is a synthetic hexapeptide growth hormone-releasing peptide (GHRP) that acts as a potent agonist of the ghrelin receptor (GHSR-1a), stimulating growth hormone release from pituitary somatotrophs. Preclinical research has studied hexarelin for its GH-stimulating properties, cardioprotective effects, and interactions with both the ghrelin receptor and CD36, a scavenger receptor also engaged by hexarelin in cardiovascular tissue research.
Read research overview →
NAD+ (Nicotinamide Adenine Dinucleotide) Research Overview
Simplified Summary Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme present in all living cells, functioning as a critical electron carrier in cellular energy metabolism and as a substrate for a broad class of enzymes including sirtuins, PARPs, and CD38. Preclinical research has studied NAD+ biology extensively in the context of ageing, metabolic regulation, mitochondrial function, and DNA repair in cell culture and animal model systems.
Read research overview →
Glutathione (GSH) Research Overview
Simplified Summary Glutathione (γ-L-glutamyl-L-cysteinyl-glycine, GSH) is the most abundant intracellular thiol antioxidant, synthesised in virtually all mammalian cells and functioning as a central mediator of cellular redox homeostasis, xenobiotic detoxification, and immune regulation. Preclinical research has studied glutathione biology extensively across oxidative stress, liver biology, immune function, and ageing research model systems.
Read research overview →
Melanotan-I and Melanotan-II (Melanocortin Receptor Agonists) Research Overview
Simplified Summary Melanotan-I (afamelanotide) and Melanotan-II are synthetic analogues of alpha-melanocyte-stimulating hormone (α-MSH), studied in preclinical models as melanocortin receptor agonists. Preclinical research has characterised their effects on melanogenesis, pigmentation biology, and melanocortin receptor pharmacology across in vitro and animal model systems.
Read research overview →
PT-141 (Bremelanotide) Melanocortin Research Overview
Simplified Summary PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan-II, studied in preclinical models for its central nervous system melanocortin receptor engagement and effects on sexual function biology. Preclinical research has characterised its melanocortin receptor pharmacology, central distribution, and behavioural effects in relevant animal model systems.
Read research overview →
Human Chorionic Gonadotropin (HCG) Research Overview
Simplified Summary Human chorionic gonadotropin (hCG) is a glycoprotein hormone structurally related to luteinising hormone (LH), sharing the same alpha subunit and differing in its beta subunit. Preclinical research has studied hCG for its luteinising hormone receptor (LHR) agonist properties, effects on gonadal steroidogenesis, and reproductive biology in cell culture and animal model systems.
Read research overview →
Human Menopausal Gonadotropin (HMG) Research Overview
Simplified Summary Human menopausal gonadotropin (hMG) is a purified preparation containing both follicle-stimulating hormone (FSH) and luteinising hormone (LH) activity, used as a research tool for studying gonadotropin receptor biology, folliculogenesis, and reproductive endocrinology in preclinical model systems.
Read research overview →
Kisspeptin (KISS1) Peptide Research Overview
Simplified Summary Kisspeptin is a neuropeptide encoded by the KISS1 gene that acts as a potent activator of the hypothalamic-pituitary-gonadal (HPG) axis through its receptor KISS1R (GPR54). Preclinical research has established kisspeptin as a master regulator of GnRH neuron activation and the central trigger for pubertal onset, reproductive cyclicity, and feedback regulation of gonadotropin secretion in laboratory model systems.
Read research overview →
Oxytocin Peptide Research Overview
Simplified Summary Oxytocin is a nine-amino acid neuropeptide synthesised in the hypothalamic paraventricular and supraoptic nuclei and released both peripherally from the posterior pituitary and centrally from hypothalamic projections. Preclinical research has studied oxytocin extensively across reproductive biology, social behaviour neuroscience, metabolic regulation, and anxiety/stress biology in diverse animal model systems.
Read research overview →
Khavinson Short Peptide Bioregulators Research Overview
Simplified Summary Khavinson peptide bioregulators are a class of short (2–4 amino acid) synthetic peptides developed by Russian researcher Vladimir Khavinson and colleagues, designed to interact with gene promoter regions and modulate the expression of tissue-specific proteins. Preclinical research has studied these peptides for their putative cytoprotective, gene-regulatory, and organ-specific biological effects in cell culture and animal model systems.
Read research overview →
VIP (Vasoactive Intestinal Peptide) Research Overview
Simplified Summary Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide widely expressed in the nervous system, immune cells, and peripheral tissues where it functions as a potent vasodilator, immunomodulator, and circadian rhythm regulator. Preclinical research has studied VIP biology across respiratory physiology, immune regulation, neuroprotection, and circadian biology in diverse animal model systems.
Read research overview →
PNC-27 Peptide Research Overview
Simplified Summary PNC-27 is a synthetic peptide comprising a sequence corresponding to the MDM-2-binding domain of the p53 tumour suppressor protein fused to an HDM-2-binding transmembrane penetratin sequence. Preclinical research has studied PNC-27 as a research tool for investigating p53-MDM2 interactions and membrane-active mechanisms in cancer cell biology in laboratory model systems.
Read research overview →
Abaloparatide and Teriparatide (PTH Receptor Agonists) Bone Biology Research Overview
Simplified Summary Abaloparatide and teriparatide are synthetic PTH-related peptides that act as agonists at the parathyroid hormone 1 receptor (PTH1R), studied in preclinical models for their bone anabolic and remodelling effects. Preclinical research has characterised their differential receptor engagement profiles and compared their effects on osteoblast activity, bone formation markers, and skeletal microarchitecture in relevant animal model systems.
Read research overview →
Glow Blend — Cosmetic Peptide Research Overview
Simplified Summary Glow Blend is a multi-peptide research compound formulated for cosmetic and skin biology research applications, combining peptides studied for their effects on collagen synthesis, skin cell biology, melanogenesis, and dermal extracellular matrix regulation. Preclinical research relevant to its component peptides has examined effects on fibroblast biology, collagen production, and skin tissue models.
Read research overview →
Klow Blend — Research Overview
Simplified Summary Klow Blend is a multi-component research formulation studied in laboratory settings for its regenerative and vitality-supporting properties. Preclinical research relevant to its component peptides spans tissue repair biology, cellular recovery mechanisms, and regenerative signalling pathway research in relevant animal model systems.
Read research overview →
Adamax — Nootropic Peptide Blend Research Overview
Simplified Summary Adamax is a nootropic research compound studied for its effects on cognitive biology, neurotrophic signalling, and neurological function in preclinical model systems. Preclinical research relevant to its component peptides encompasses neurotrophic factor biology, synaptic plasticity research, and cognitive neuroscience in cell culture and animal model systems.
Read research overview →